ENST00000372348.9:c.137-63877C>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000372348.9(ABL1):​c.137-63877C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.221 in 152,158 control chromosomes in the GnomAD database, including 5,026 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 5026 hom., cov: 33)

Consequence

ABL1
ENST00000372348.9 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.205

Publications

4 publications found
Variant links:
Genes affected
ABL1 (HGNC:76): (ABL proto-oncogene 1, non-receptor tyrosine kinase) This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]
ABL1 Gene-Disease associations (from GenCC):
  • congenital heart defects and skeletal malformations syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
  • connective tissue disorder
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • bone development disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.431 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABL1NM_007313.3 linkc.137-63877C>A intron_variant Intron 1 of 10 NP_009297.2 P00519-2Q59FK4
LOC124902288XR_007061823.1 linkn.247-7393G>T intron_variant Intron 2 of 2
LOC124902288XR_007061824.1 linkn.247-2507G>T intron_variant Intron 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABL1ENST00000372348.9 linkc.137-63877C>A intron_variant Intron 1 of 10 1 ENSP00000361423.2 P00519-2
ABL1ENST00000393293.4 linkc.137-63880C>A intron_variant Intron 1 of 1 5 ENSP00000376971.4 R4GRW0
ENSG00000309617ENST00000842460.1 linkn.243-7393G>T intron_variant Intron 2 of 4

Frequencies

GnomAD3 genomes
AF:
0.221
AC:
33598
AN:
152040
Hom.:
5018
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.436
Gnomad AMI
AF:
0.213
Gnomad AMR
AF:
0.201
Gnomad ASJ
AF:
0.120
Gnomad EAS
AF:
0.0689
Gnomad SAS
AF:
0.128
Gnomad FIN
AF:
0.118
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.135
Gnomad OTH
AF:
0.214
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.221
AC:
33649
AN:
152158
Hom.:
5026
Cov.:
33
AF XY:
0.217
AC XY:
16172
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.436
AC:
18087
AN:
41456
American (AMR)
AF:
0.201
AC:
3070
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.120
AC:
418
AN:
3472
East Asian (EAS)
AF:
0.0689
AC:
357
AN:
5182
South Asian (SAS)
AF:
0.128
AC:
618
AN:
4828
European-Finnish (FIN)
AF:
0.118
AC:
1249
AN:
10596
Middle Eastern (MID)
AF:
0.167
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
0.135
AC:
9154
AN:
68020
Other (OTH)
AF:
0.214
AC:
453
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1203
2406
3608
4811
6014
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
326
652
978
1304
1630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.189
Hom.:
489
Bravo
AF:
0.236
Asia WGS
AF:
0.141
AC:
490
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
1.1
DANN
Benign
0.26
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11244142; hg19: chr9-133665574; API